All terms in EFO
| Label | Id | Description |
|---|---|---|
| quality | BFO_0000019 | [A quality is an entity that describes some aspect which is intrinsic to that particular object and is dependent on or more material entities in which it inheres in or is borne by. Example the color of a tomato, the ambient temperature of air, the circumference of a waist, the shape of a nose, the mass of a piece of gold, the weight of a chimpanzee] |
| feeling "fed-up" measurement | EFO_0009588 | [Quantification of whether an individual feels or felt "fed-up".] |
| emotional symptom measurement | EFO_0007803 | [quantification of some aspect of emotional problem symptoms, such as their existence and severity, usually via a standardised questionnaire such as the emotional symptoms subscale of the Strengths and Difficulties Questionnaire or interview with a qualified mental health professional] |
| response to dimethyl fumarate | EFO_0010577 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus with dimethyl fumarate] |
| dimethyl fumarate | CHEBI_76004 | [An enoate ester resulting from the formal condensation of both carboxy groups of fumaric acid with methanol. Used for treatment of adults with relapsing forms of multiple sclerosis.] |
| Plasmodium vivax | NCBITaxon_5855 | |
| worry measurement | EFO_0009589 | [Quantification of whether an individual feels or felt worried.] |
| complex trait | EFO_0010578 | [A trait which cannot be accurately represented using standard EFO terms, e.g. a statistical combination of many unrelated traits. This term may also be used as a parent term for GWAS Catalog entries which include many analyses on unrelated traits.] |
| vascular endothelial growth factor D measurement | EFO_0010575 | [Quantification of the amount of Vascular Endothelial Growth Factor D in the sample.] |
| liver fibrosis measurement | EFO_0010576 | [Quantification of the invasion of fibrous connective tissue into the liver, typically by histological assessment of biopsy samples.] |
| liver disease biomarker | EFO_0006845 | [The quantification of biomarkers used in the diagnosis or management of liver disease] |
| liver | UBERON_0002107 | [An exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes[GO].] |
| Hepatic fibrosis | HP_0001395 | [The presence of excessive fibrous connective tissue in the liver. Fibrosis is a reparative or reactive process.] |
| AQP4-IgG-positive neuromyelitis optica | EFO_0009584 | [A subtype of neuromyelitis optica caused by an autoimmune aquaporin-4 channelopathy, due to presence of circulating autoantibodies against aquaporin 4.] |
| neuromyelitis optica | EFO_0004256 | [A syndrome characterized by acute OPTIC NEURITIS in combination with acute MYELITIS, TRANSVERSE. Demyelinating and/or necrotizing lesions form in one or both optic nerves and in the spinal cord. The onset of optic neuritis and myelitis may be simultaneous or separated by several months. (J Neurol Neurosurg Psychiatry 1996 Apr;60(4):382-387)., Neuromyelitis optica (NMO) and NMO spectrum disorders are inflammatory demyelinating diseases of the central nervous system characterized mainly by attacks of uni- or bilateral optic neuritis (ON) and acute myelitis.] |
| kallikrein-11 measurement | EFO_0010573 | [Quantification of the amount of kallikrein-11 in a sample.] |
| congenital bile acid synthesis defect 4 | MONDO_0008967 | [An anomaly of bile acid synthesis characterized by mild cholestatic liver disease, fat malabsorption and/or neurological disease.] |
| Alpha-methylacyl-CoA racemase deficiency | EFO_1001980 | [A rare disorder caused by mutation in the AMACR gene. Racemization is the prerequisite to beta-oxidation for branched chain fatty acids and bile acids. It is characterized by neurological abnormalities that appear in adulthood and include cognitive decline, seizures, and sensorimotor neuropathy. AMACR deficiency rarely presents as liver disease in infancy., A rare disorder caused by mutation in the AMACR gene. It is characterized by neurological abnormalities that appear in adulthood and include cognitive decline, seizures, and sensorimotor neuropathy.] |
| epithelial cell adhesion molecule measurement | EFO_0010574 | [Quantification of the amount of epithelial cell adhesion molecule in a sample.] |
| AQP4-IgG-negative neuromyelitis optica | EFO_0009585 | [A subtype of neuromyelitis optica caused by an antiMOG associated encephalomyelitis.] |